Argus Research Reiterates Hold on Bath & Body Worksto Hold
Argus Research analyst Taylor Conrad reiterates Bath & Body Works (NYSE:BBWI) from Hold to Hold.
Stocks · News reference
Morgan Stanley Maintains Equal-Weight on Bath & Body Works, Lowers Price Target to $20
Morgan Stanley analyst Alex Straton maintains Bath & Body Works (NYSE:BBWI) with a Equal-Weight and lowers the price target from $22 to $20.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of retail-related consumer discretionary companies are trading lower as energy prices remain elevated, a Fed rate hike on September 16 becomes base case, and traders assess the outlook for more monetary tightening in 2026 and 2027 ahead of the crucial holiday season.
'Barington Takes New Stake in Bath & Body Works, Pushing for Sale' - Bloomberg News
https://www.bloomberg.com/news/articles/2026-09-10/barington-takes-new-stake-in-bath-body-works-pushing-for-sale
BMO Capital Initiates Coverage On Bath & Body Works with Market Perform Rating, Announces Price Target of $20
BMO Capital analyst Kelly Crago initiates coverage on Bath & Body Works (NYSE:BBWI) with a Market Perform rating and announces Price Target of $20.